CoChat

Chronic IL-1β-induced inflammation regulates epithelial-to-mesenchymal transition memory phenotypes via epigenetic modifications in non-small cell lung cancer

Open access
Li, Rui, Ong, Stephanie L., Tran, Linh M., Jing, Zhe, Liu, Bin, Park, Stacy J., Huang, Zi Ling, Walser, Tonya C., Heinrich, Eileen L., Lee, Gina, Salehi-Rad, Ramin, Crosson, William P., Pagano, Paul C., Paul, Manash K., Xu, Shili, Herschman, Harvey, Krysan, Kostyantyn, Dubinett, Steven · 2020 · Scientific Reports
Cited by 116

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

Chronic inflammation facilitates tumor progression. We discovered that a subset of non-small cell lung cancer cells underwent a gradually progressing epithelial-to-mesenchymal (EMT) phenotype following a 21-day exposure to IL-1β, an abundant proinflammatory cytokine in the at-risk for lung cancer pulmonary and the lung tumor microenvironments. Pathway analysis of the gene expression profile and in vitro functional studies revealed that the EMT and EMT-associated phenotypes, including enhanced cell invasion, PD-L1 upregulation, and chemoresistance, were sustained in the absence of continuous IL-1β exposure. We referred to this phenomenon as EMT memory. Utilizing a doxycycline-controlled SLUG expression system, we found that high expression of the transcription factor SLUG was indispensable for the establishment of EMT memory. High SLUG expression in tumors of lung cancer patients was associated with poor survival. Chemical or genetic inhibition of SLUG upregulation prevented EMT following the acute IL-1β exposure but did not reverse EMT memory. Chromatin immunoprecipitation and methylation-specific PCR further revealed a SLUG-mediated temporal regulation of epigenetic modifications, including accumulation of H3K27, H3K9, and DNA methylation, in the CDH1 (E-cadherin) promoter following the chronic IL-1β exposure. Chemical inhibition of DNA methylation not only restored E-cadherin expression in EMT memory, but also primed cells for chemotherapy-induced apoptosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-019-57285-y

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Research works printed but not linked: 45

  1. Coussens, L. M. & Werb, Z. Inflammation and cancer. Nature 420, 860–867, https://doi.org/10.1038/nature01322 (2002). · DOI · Paper page
  2. Grivennikov, S. I., Greten, F. R. & Karin, M. Immunity, inflammation, and cancer. Cell 140, 883–899, https://doi.org/10.1016/j.cell.2010.01.025 (2010). · DOI · Paper page
  3. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646–674, https://doi.org/10.1016/j.cell.2011.02.013 (2011). · DOI · Paper page
  4. Houghton, A. M. Mechanistic links between COPD and lung cancer. Nat Rev Cancer 13, 233–245, https://doi.org/10.1038/nrc3477 (2013). · DOI · Paper page
  5. Wilson, D. O. et al. Association of radiographic emphysema and airflow obstruction with lung cancer. Am J Respir Crit Care Med 178, 738–744, https://doi.org/10.1164/rccm.200803-435OC (2008). · DOI · Paper page
  6. Collins, R. H. Jr., Feldman, M. & Fordtran, J. S. Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis. A critical review. N Engl J Med 316, 1654–1658, https://doi.org/10.1056/NEJM198706253162609 (1987). · DOI · Paper page
  7. Cuzick, J. et al. Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. Lancet Oncol 10, 501–507, https://doi.org/10.1016/S1470-2045(09)70035-X (2009). · DOI · Paper page
  8. Wu, C. et al. Correlation between serum IL-1beta and miR-144-3p as well as their prognostic values in LUAD and LUSC patients. Oncotarget 7, 85876–85887, https://doi.org/10.18632/oncotarget.13042 (2016). · DOI
  9. Millares, L. et al. Tumor-associated metabolic and inflammatory responses in early stage non-small cell lung cancer: Local patterns and prognostic significance. Lung Cancer 122, 124–130, https://doi.org/10.1016/j.lungcan.2018.06.015 (2018). · doi:10.1016/j.lungcan.2018.06.015
  10. Shiels, M. S. et al. Circulating inflammation markers and prospective risk for lung cancer. J Natl Cancer Inst 105, 1871–1880, https://doi.org/10.1093/jnci/djt309 (2013). · DOI · Paper page
  11. Krysan, K. et al. Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner. Cancer Res 65, 6275–6281, https://doi.org/10.1158/0008-5472.CAN-05-0216 (2005). · DOI · Paper page
  12. Dohadwala, M. et al. Cyclooxygenase-2-dependent regulation of E-cadherin: prostaglandin E(2) induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer. Cancer Res 66, 5338–5345, https://doi.org/10.1158/0008-5472.CAN-05-3635 (2006). · DOI · Paper page
  13. Pold, M. et al. Cyclooxygenase-2-dependent expression of angiogenic CXC chemokines ENA-78/CXC Ligand (CXCL) 5 and interleukin-8/CXCL8 in human non-small cell lung cancer. Cancer Res 64, 1853–1860 (2004). · DOI · Paper page
  14. St John, M. A. et al. Proinflammatory mediators upregulate snail in head and neck squamous cell carcinoma. Clin Cancer Res 15, 6018–6027, https://doi.org/10.1158/1078-0432.CCR-09-0011 (2009). · DOI
  15. Lee, J. M. et al. Inflammation in lung carcinogenesis: new targets for lung cancer chemoprevention and treatment. Crit Rev Oncol Hematol 66, 208–217, https://doi.org/10.1016/j.critrevonc.2008.01.004 (2008). · DOI
  16. Masola, V. et al. In vitro effects of interleukin (IL)-1 beta inhibition on the epithelial-to-mesenchymal transition (EMT) of renal tubular and hepatic stellate cells. J Transl Med 17, 12, https://doi.org/10.1186/s12967-019-1770-1 (2019). · DOI · Paper page
  17. Wu, T. et al. Modulation of IL-1beta reprogrammes the tumor microenvironment to interrupt oral carcinogenesis. Sci Rep 6, 20208, https://doi.org/10.1038/srep20208 (2016). · DOI
  18. Chambers, A. F., Groom, A. C. & MacDonald, I. C. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2, 563–572, https://doi.org/10.1038/nrc865 (2002). · DOI · Paper page
  19. Thiery, J. P. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2, 442–454, https://doi.org/10.1038/nrc822 (2002). · DOI · Paper page
  20. Ye, X. & Weinberg, R. A. Epithelial-Mesenchymal Plasticity: A Central Regulator of Cancer Progression. Trends Cell Biol 25, 675–686, https://doi.org/10.1016/j.tcb.2015.07.012 (2015). · DOI · Paper page
  21. Giannou, A. D. et al. Mast cells mediate malignant pleural effusion formation. J Clin Invest 125, 2317–2334, https://doi.org/10.1172/JCI79840 (2015). · DOI · Paper page
  22. Walser, T. C. et al. Silencing the Snail-Dependent RNA Splice Regulator ESRP1 Drives Malignant Transformation of Human Pulmonary Epithelial Cells. Cancer Res 78, 1986–1999, https://doi.org/10.1158/0008-5472.CAN-17-0315 (2018). · DOI
  23. Tsai, J. H., Donaher, J. L., Murphy, D. A., Chau, S. & Yang, J. Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell 22, 725–736, https://doi.org/10.1016/j.ccr.2012.09.022 (2012). · DOI · Paper page
  24. Tam, W. L. & Weinberg, R. A. The epigenetics of epithelial-mesenchymal plasticity in cancer. Nat Med 19, 1438–1449, https://doi.org/10.1038/nm.3336 (2013). · DOI · Paper page
  25. Lou, Y. et al. Epithelial-Mesenchymal Transition Is Associated with a Distinct Tumor Microenvironment Including Elevation of Inflammatory Signals and Multiple Immune Checkpoints in Lung Adenocarcinoma. Clin Cancer Res 22, 3630–3642, https://doi.org/10.1158/1078-0432.CCR-15-1434 (2016). · DOI · Paper page
  26. Chae, Y. K. et al. Epithelial-mesenchymal transition (EMT) signature is inversely associated with T-cell infiltration in non-small cell lung cancer (NSCLC). Sci Rep 8, 2918, https://doi.org/10.1038/s41598-018-21061-1 (2018). · DOI · Paper page
  27. Javaid, S. et al. Dynamic chromatin modification sustains epithelial-mesenchymal transition following inducible expression of Snail-1. Cell Rep 5, 1679–1689, https://doi.org/10.1016/j.celrep.2013.11.034 (2013). · DOI · Paper page
  28. Dong, C. et al. G9a interacts with Snail and is critical for Snail-mediated E-cadherin repression in human breast cancer. J Clin Invest 122, 1469–1486, https://doi.org/10.1172/JCI57349 (2012). · DOI · Paper page
  29. Schwartsmann, G. et al. A phase I trial of cisplatin plus decitabine, a new DNA-hypomethylating agent, in patients with advanced solid tumors and a follow-up early phase II evaluation in patients with inoperable non-small cell lung cancer. Invest New Drugs 18, 83–91 (2000). · DOI
  30. Katsuno, Y. et al. Chronic TGF-beta exposure drives stabilized EMT, tumor stemness, and cancer drug resistance with vulnerability to bitopic mTOR inhibition. Sci Signal 12, https://doi.org/10.1126/scisignal.aau8544 (2019). · DOI · Paper page
  31. Marazioti, A. et al. Myeloid-derived interleukin-1beta drives oncogenic KRAS-NF-kappaBeta addiction in malignant pleural effusion. Nat Commun 9, 672, https://doi.org/10.1038/s41467-018-03051-z (2018). · DOI
  32. Szczerba, B. M. et al. Neutrophils escort circulating tumour cells to enable cell cycle progression. Nature 566, 553–557, https://doi.org/10.1038/s41586-019-0915-y (2019). · DOI · Paper page
  33. Epsztejn-Litman, S. et al. De novo DNA methylation promoted by G9a prevents reprogramming of embryonically silenced genes. Nat Struct Mol Biol 15, 1176–1183, https://doi.org/10.1038/nsmb.1476 (2008). · DOI · Paper page
  34. Mohn, F. et al. Lineage-specific polycomb targets and de novo DNA methylation define restriction and potential of neuronal progenitors. Mol Cell 30, 755–766, https://doi.org/10.1016/j.molcel.2008.05.007 (2008). · DOI · Paper page
  35. Rougeulle, C. et al. Differential histone H3 Lys-9 and Lys-27 methylation profiles on the X chromosome. Mol Cell Biol 24, 5475–5484, https://doi.org/10.1128/MCB.24.12.5475-5484.2004 (2004). · DOI · Paper page
  36. Mozzetta, C. et al. The histone H3 lysine 9 methyltransferases G9a and GLP regulate polycomb repressive complex 2-mediated gene silencing. Mol Cell 53, 277–289, https://doi.org/10.1016/j.molcel.2013.12.005 (2014). · DOI · Paper page
  37. Bintu, L. et al. Dynamics of epigenetic regulation at the single-cell level. Science 351, 720–724, https://doi.org/10.1126/science.aab2956 (2016). · DOI · Paper page
  38. Juergens, R. A. et al. Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancer. Cancer Discov 1, 598–607, https://doi.org/10.1158/2159-8290.CD-11-0214 (2011). · DOI · Paper page
  39. Topalian, S. L. et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med 366, 2443–2454, https://doi.org/10.1056/NEJMoa1200690 (2012). · DOI · Paper page
  40. Xu, S. et al. Hexokinase 2 is targetable for HK1 negative, HK2 positive tumors from a wide variety of tissues of origin. J Nucl Med, https://doi.org/10.2967/jnumed.118.212365 (2018). · DOI
  41. Pagano, P. C. et al. Identification of a Human Airway Epithelial Cell Subpopulation with Altered Biophysical, Molecular, and Metastatic Properties. Cancer Prev Res (Phila) 10, 514–524, https://doi.org/10.1158/1940-6207.CAPR-16-0335 (2017). · DOI
  42. Liclican, E. L. et al. Loss of miR125a expression in a model of K-ras-dependent pulmonary premalignancy. Cancer Prev Res (Phila) 7, 845–855, https://doi.org/10.1158/1940-6207.CAPR-14-0063 (2014). · DOI
  43. Graff, J. R., Herman, J. G., Myohanen, S., Baylin, S. B. & Vertino, P. M. Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation. J Biol Chem 272, 22322–22329 (1997). · DOI · Paper page
  44. Anders, S., Pyl, P. T. & Huber, W. HTSeq–a Python framework to work with high-throughput sequencing data. Bioinformatics 31, 166–169, https://doi.org/10.1093/bioinformatics/btu638 (2015). · DOI · Paper page
  45. Conesa, A., Nueda, M. J., Ferrer, A. & Talon, M. maSigPro: a method to identify significantly differential expression profiles in time-course microarray experiments. Bioinformatics 22, 1096–1102, https://doi.org/10.1093/bioinformatics/btl056 (2006). · DOI · Paper page

Cited by

See all 116

Metadata

Authors
Li, R., Ong, S. L., Tran, L. M., Jing, Z., Liu, B., Park, S. J., Huang, Z. L., Walser, T. C., Heinrich, E. L., Lee, G., Salehi-Rad, R., Crosson, W. P., Pagano, P. C., Paul, M. K., Xu, S., Herschman, H., Krysan, K., & Dubinett, S.
Venue
Scientific Reports
Published
2020-01-15
Volume
10
Issue
1
Pages
377-377
ISSN
2045-2322 (ISSN-L)
OpenAlex
W3000456443
Cited by
116
References
15
FWCI
4.97
Type
journal article
Language
en
Open access
gold
Licence
Funders
  • U.S. Department of Health & Human Services | NIH | National Cancer Institute (1U01CA196408)
  • EIF | Stand Up To Cancer (AACR-DT23-17)
  • U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (UL1TR001881)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Chronic IL-1β-induced inflammation regulates epithelial-to-mesenchymal transition memory phenotypes via epigenetic modifications in non-small cell lung cancer. https://app.cochat.ai/papers/10.1038/s41598-019-57285-y
The paper
Li, R., Ong, S. L., Tran, L. M., Jing, Z., Liu, B., Park, S. J., Huang, Z. L., Walser, T. C., Heinrich, E. L., Lee, G., Salehi-Rad, R., Crosson, W. P., Pagano, P. C., Paul, M. K., Xu, S., Herschman, H., Krysan, K., & Dubinett, S. (2020). Chronic IL-1β-induced inflammation regulates epithelial-to-mesenchymal transition memory phenotypes via epigenetic modifications in non-small cell lung cancer. Scientific Reports. https://doi.org/10.1038/s41598-019-57285-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.